Tracking of Vβ8.2-Positive Encephalitogenic T Cells by Complementarity-Determining Region 3 Spectratyping and Subsequent Southern Blot Hybridization in Lewis Rats after Neuroantigen Sensitization1
Tracking of Vβ8.2-Positive Encephalitogenic T Cells by Complementarity-Determining Region 3 Spectratyping and Subsequent Southern Blot Hybridization in Lewis Rats after Neuroantigen Sensitization1
复制标题
神经抗原致敏后,通过互补决定区 3 光谱分型和随后的 Southern 印迹杂交追踪 Vβ8.2 阳性致脑炎 T 细胞1
作者:
H. Sakuma;K. Kohyama;Y. Jee;Y. Matsumoto
Pathogenic T cells in organ-specific autoimmune diseases use a limited number of TCR α- and β-chains. In experimental autoimmune encephalomyelitis (EAE) induced in Lewis rats by immunization with myelin basic protein, encephalitogenic T cells mainly use Vβ8.2 TCR and clonal expansion of the Vβ8.2 spectratype containing the EAE-specific complementarity-determining region 3 (CDR3) sequence, DSSYEQYFGPG, is found in the spinal cord throughout the course of clinical EAE. In the present study we performed temporal and spatial analyses of Vβ8.2 spectratype expansion by CDR3 spectratyping and subsequent DNA hybridization with a probe specific for the encephalitogenic CDR3 sequence to elucidate the kinetics of encephalitogenic T cells during the induction phase after neuroantigen sensitization. It was demonstrated that Vβ8.2 spectratype expansion and/or the positive signal in Southern blot were first detected in the regional lymph nodes as early as day 3 postimmunization and was disseminated over the lymphoid organs by day 6. Because perfusion of immunized rats with PBS erased the positive signals on day 3 postimmunization, the majority of Vβ8.2-positive encephalitogenic T cells at the very early stage would reside within the lymphatic or blood vessels. Furthermore, removal of the draining lymph node 1, 3, and 6 days after immunization in the foot pad did not ameliorate clinical EAE. These findings strongly suggest that encephalitogenic T cells disseminate throughout the whole body very rapidly after sensitization. Analysis of pathogenic T cells at the clonal level provides useful information for designing effective immunotherapy.
DOI:
10.1172/jci18337
发表时间:
2003
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Stratmann,Thomas;Martin-Orozco,Natalia;Mallet-Designe,Valerie;Poirot,Laurent;McGavern,Dorian;Losyev,Grigoriy;Dobbs,CathleenM;Oldstone,MichaelBA;Yoshida,Kenji;Kikutani,Hitoshi;Mathis,Diane;Benoist,Christophe;Haskins,Kathryn;Tey
通讯作者:
Tey